Oppenheimer Asset Management’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-43,001
| Closed | -$228K | – | 1164 |
|
|
2024
Q1 | $228K | Buy |
43,001
+19,094
| +80% | +$101K | ﹤0.01% | 1021 |
|
|
2023
Q4 | $148K | Sell |
23,907
-9,625
| -29% | -$59.6K | ﹤0.01% | 1122 |
|
|
2023
Q3 | $253K | Sell |
33,532
-31,443
| -48% | -$237K | ﹤0.01% | 999 |
|
|
2023
Q2 | $628K | Buy |
64,975
+6,975
| +12% | +$67.4K | 0.01% | 803 |
|
|
2023
Q1 | $219K | Sell |
58,000
-19,221
| -25% | -$72.6K | ﹤0.01% | 1032 |
|
|
2022
Q4 | $500K | Sell |
77,221
-4,690
| -6% | -$30.4K | 0.01% | 860 |
|
|
2022
Q3 | $728K | Sell |
81,911
-704
| -0.9% | -$6.26K | 0.01% | 748 |
|
|
2022
Q2 | $824K | Buy |
82,615
+21,498
| +35% | +$214K | 0.01% | 729 |
|
|
2022
Q1 | $708K | Buy |
61,117
+6,638
| +12% | +$76.9K | 0.01% | 837 |
|
|
2021
Q4 | $605K | Buy |
54,479
+675
| +1% | +$7.5K | 0.01% | 914 |
|
|
2021
Q3 | $496K | Buy |
53,804
+3,423
| +7% | +$31.6K | 0.01% | 938 |
|
|
2021
Q2 | $567K | Buy |
50,381
+3,598
| +8% | +$40.5K | 0.01% | 915 |
|
|
2021
Q1 | $496K | Buy |
46,783
+22,207
| +90% | +$235K | 0.01% | 915 |
|
|
2020
Q4 | $267K | Buy |
24,576
+12,305
| +100% | +$134K | ﹤0.01% | 1012 |
|
|
2020
Q3 | $119K | Buy |
+12,271
| New | +$119K | ﹤0.01% | 1053 |
|